158 related articles for article (PubMed ID: 9516457)
21. Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2.
Sahni A; Francis CW
J Thromb Haemost; 2003 Jun; 1(6):1271-7. PubMed ID: 12871330
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
Sangrar W; Koschinsky ML
Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
[TBL] [Abstract][Full Text] [Related]
23. The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation.
Schenk S; Chiquet-Ehrismann R; Battegay EJ
Mol Biol Cell; 1999 Sep; 10(9):2933-43. PubMed ID: 10473637
[TBL] [Abstract][Full Text] [Related]
24. Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF.
Gualandris A; Urbinati C; Rusnati M; Ziche M; Presta M
J Cell Physiol; 1994 Oct; 161(1):149-59. PubMed ID: 7929600
[TBL] [Abstract][Full Text] [Related]
25. C1q component of complement binds to fibrinogen and fibrin.
Entwistle RA; Furcht LT
Biochemistry; 1988 Jan; 27(1):507-12. PubMed ID: 3258162
[TBL] [Abstract][Full Text] [Related]
26. Binding, internalization, and degradation of basic fibroblast growth factor in human microvascular endothelial cells.
Bikfalvi A; Dupuy E; Inyang AL; Fayein N; Leseche G; Courtois Y; Tobelem G
Exp Cell Res; 1989 Mar; 181(1):75-84. PubMed ID: 2917611
[TBL] [Abstract][Full Text] [Related]
27. Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan.
Deguchi Y; Okutsu H; Okura T; Yamada S; Kimura R; Yuge T; Furukawa A; Morimoto K; Tachikawa M; Ohtsuki S; Hosoya K; Terasaki T
J Neurochem; 2002 Oct; 83(2):381-9. PubMed ID: 12423248
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells.
Moscatelli D
J Cell Biol; 1988 Aug; 107(2):753-9. PubMed ID: 2843546
[TBL] [Abstract][Full Text] [Related]
29. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
Hayashi S; Yamada K
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
[TBL] [Abstract][Full Text] [Related]
30. Crosslinking of fibrinogen to immobilized DesAA-fibrin.
Selmayr E; Thiel W; Müller-Berghaus G
Thromb Res; 1985 Aug; 39(4):459-65. PubMed ID: 4049326
[TBL] [Abstract][Full Text] [Related]
31. The structure and biological features of fibrinogen and fibrin.
Mosesson MW; Siebenlist KR; Meh DA
Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
[TBL] [Abstract][Full Text] [Related]
32. Identification of a binding site on human FGF-2 for fibrinogen.
Peng H; Sahni A; Fay P; Bellum S; Prudovsky I; Maciag T; Francis CW
Blood; 2004 Mar; 103(6):2114-20. PubMed ID: 14630795
[TBL] [Abstract][Full Text] [Related]
33. Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells.
Emoto N; Isozaki O; Ohmura E; Shizume K; Tsushima T; Demura H
Thyroid; 1995 Dec; 5(6):455-60. PubMed ID: 8808095
[TBL] [Abstract][Full Text] [Related]
34. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
Galanakis DK; Ghebrehiwet B
J Clin Invest; 1994 Jan; 93(1):303-10. PubMed ID: 8282801
[TBL] [Abstract][Full Text] [Related]
35. bFGF- and CaPP-Loaded Fibrin Clots Enhance the Bioactivity of the Tendon-Bone Interface to Augment Healing.
Zhang C; Li Q; Deng S; Fu W; Tang X; Chen G; Qin T; Li J
Am J Sports Med; 2016 Aug; 44(8):1972-82. PubMed ID: 27159301
[TBL] [Abstract][Full Text] [Related]
36. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
Thiel W; Delvos U; Müller-Berghaus G
Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
[TBL] [Abstract][Full Text] [Related]
38. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach.
Gleizes PE; Noaillac-Depeyre J; Amalric F; Gas N
Eur J Cell Biol; 1995 Jan; 66(1):47-59. PubMed ID: 7750519
[TBL] [Abstract][Full Text] [Related]
39. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor.
Flaumenhaft R; Moscatelli D; Rifkin DB
J Cell Biol; 1990 Oct; 111(4):1651-9. PubMed ID: 2170425
[TBL] [Abstract][Full Text] [Related]
40. Modulation of basic fibroblast growth factor effect by retinoic acid in cultured retinal pigment epithelium.
Kusaka K; Kothary PC; Del Monte MA
Curr Eye Res; 1998 May; 17(5):524-30. PubMed ID: 9617548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
